美容注射市場：市場規模（セグメント別）、シェア、法規制、償還、手技、予測（～2033年）

美容注射とは、より若々しい外観を取り戻すために皮膚の下に注入するジェル状の物質を指します。これは、くぼんだ頬やこめかみのボリュームを増やしたり、鼻や口の周りのシワ（マリオネットラインやスマイルライン）を減らしたり、唇をふっくらさせたり、顔の輪郭を強調したりすることで達成されます。美容注射は、非外科的で非侵襲的であるため、人気が高まっています。

さらに、成功した結果は、限られた回復時間で迅速に達成されます。美容注射市場が成長するにつれて、外科医が利用できる注射フィラーの数と種類が増加しています。

当レポートは、世界の美容注射市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている美容注射と競合情勢

• 主要な業界動向の洞察
• 美容注射のセグメント別総市場収益と2015年～2033年の市場展望
• セグメント別の手技総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 美容注射市場のSWOT分析
• 美容注射市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Aesthetic Injectables Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Aesthetic Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Aesthetic Injectables market for the year 2020 and beyond. Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. This is achieved by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour. Aesthetic Injectables are rising in popularity, due to the non-surgical and non-invasive nature of these procedures.

In addition, successful outcomes are achieved quickly with limited recovery time. As the aesthetic injectables market grows, the number and variety of injectable fillers available to surgeons is increasing.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Aesthetic Injectables and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Aesthetic Injectables market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices, and market values by segment.

Global, Regional, and Country level market specific insights -

• Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
• SWOT analysis for the Aesthetic Injectables market.
• Competitive dynamics insights and trends provided for the Aesthetic Injectables market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country-specific overview of the healthcare system.
• Country-specific reimbursement policies.
• Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: AbbVie Inc, Galderma SA, Merz Pharma GmbH & Co KgaA, Huadong Medicine Co Ltd, Teoxane SA, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Aesthetic Injectables marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Aesthetic Injectables market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Aesthetic Injectables market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Aesthetic Injectables market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Aesthetic Injectables market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable